Rankings
▼
Calendar
AXSM Q1 2022 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AXSM
Axsome Therapeutics, Inc.
$9B
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$38M
Net Income
-$40M
EPS (Diluted)
$-1.03
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$33M
Free Cash Flow
-$33M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$89M
Total Liabilities
$74M
Stockholders' Equity
$15M
Cash & Equivalents
$85M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$38M
-$28M
-37.5%
Net Income
-$40M
-$29M
-35.4%
← FY 2022
All Quarters
Q2 2022 →